سعر سيفاكسون 250مجم فيال وريد 2024

Cefaxone 250mg i.v. vial.: Ceftriaxone (Pharco b).

• Parenteral third-generation cephalosporin for susceptible infections including lower respiratory tract, skin/skin structure, urinary tract, uncomplicated gonorrhea, pelvic inflammatory disease, bacterial septicemia, bone and joint, intra-abdominal, meningitis, and surgical prophylaxis as labeled (US ceftriaxone injectable labeling).Population: AdultsDailyMed (U.S. National Library of Medicine)

• Contraindicated with known hypersensitivity to ceftriaxone, its excipients, or other cephalosporins; do not use in hyperbilirubinemic neonates or concurrent IV calcium in neonates as labeled (US labels).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Fatal ceftriaxone–calcium precipitation reported in neonates; gallbladder sludge/pseudolithiasis; pancreatitis rare; C. difficile diarrhea; neurological adverse reactions reported (US labels).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Calcium-containing IV solutionsDo not mix/co-administer IV ceftriaxone with calcium-containing IV solutions in neonates; risk of precipitation (US boxed-style warning).DailyMed (U.S. National Library of Medicine)
• AminoglycosidesPossible additive nephrotoxicity; monitor.DailyMed (U.S. National Library of Medicine)

• Animal studies without teratogenicity at multiples of human dose; limited controlled human data — use only if clearly needed (US labels).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Ceftriaxone: Long-acting third-generation cephalosporin inhibiting cell-wall synthesis via PBP binding; once-daily dosing common.